Autobahn Therapeutics Funding & Investors

Autobahn Therapeutics is focused on improving life health for people affected by CNS disorders by driving the regenerative power of the human body.

Total Amount Raised: $208,700,000

Autobahn Therapeutics Funding Rounds

Series Unknown
$32,700,000
Sep 7, 2022
Series Unknown Investors
Bristol-Myers Squibb
Alexandria Venture Investments
Pfizer Venture Investments
Arch Venture Partners
Section 32
Biotechnology Value Fund
GT Healthcare Capital Partners
Samsara Biocapital
Invus Group
Cowen Healthcare Investments
Biogen
Series B
$76,000,000
Jun 10, 2020
Series B Investors
Arch Venture Partners
Cowen Healthcare Investments
Invus Group
Pfizer Venture Investments
Bristol-Myers Squibb
Samsara Biocapital
Alexandria Venture Investments
Biotechnology Value Fund
Section 32
Biogen
Series C
$100,000,000
Jul 23, 2024
Series C Investors
Newpath Partners
Alexandria Venture Investments
Blue Owl
Biogen
Section 32
Invus Group
Pfizer Venture Investments
Bristol-Myers Squibb
Canaan
Insight Partners
Monograph Capital
BVF Partners
Arch Venture Partners
Samsara Biocapital
GT Healthcare Capital Partners

Funding info provided by Diffbot.